What Are the Most Important Symptom Targets When Treating Advanced Cancer? A Survey of Providers in the National Comprehensive Cancer Network (NCCN)
暂无分享,去创建一个
David Cella | D. Cella | S. Yount | R. Winn | J. Weeks | Jane Weeks | Chih-Hung Chang | Chih-Hung Chang | Diane Paul | Susan Yount | Rodger Winn | Donald Banik | D. Banik | D. Paul
[1] D. Cella,et al. The functional assessment of cancer therapy (FACT) scale. Development of a brain subscale and revalidation of the general version (FACT‐G) in patients with primary brain tumors , 1995, Cancer.
[2] D. Pathak,et al. References for health-related quality-of-life claims in prescription drug advertisements. , 1997, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[3] Penny Hopwood. Progress, problems and priorities in quality of life research. , 1992, European journal of cancer.
[4] L. Fish,et al. Quality of life issues in the management of ovarian cancer. , 1999, Seminars in oncology.
[5] H. Thaler,et al. Symptom prevalence, characteristics and distress in a cancer population , 1994, Quality of Life Research.
[6] Skeel Rt. Quality of life dimensions that are most important to cancer patients. , 1993 .
[7] I. Wilson,et al. Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. , 1995, JAMA.
[8] R. Portenoy,et al. Symptom assessment. , 1996, Hematology/oncology clinics of North America.
[9] H. Scher,et al. The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. , 1994, European journal of cancer.
[10] D. Tulsky,et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] Jenny Morris,et al. The use of quality of life data in clinical practice , 2004, Quality of Life Research.
[12] E. Vokes,et al. The performance status scale for head and neck cancer patients and the functional assessment of cancer therapy‐head and neck scale: A study of utility and validity , 1996, Cancer.
[13] D. Funch. Predictors and Consequences of Symptom Reporting Behaviors in Colorectal Cancer Patients , 1988, Medical care.
[14] R. Kaplan,et al. Assessing health-related quality of life: application to drug therapy. , 1992, Clinical therapeutics.
[15] S. Kong,et al. Methodologic Assessments of Quality of Life Measures in Clinical Trials , 1997, The Annals of pharmacotherapy.
[16] R. Temple,et al. Food and Drug Administration requirements for approval of new anticancer drugs. , 1985, Cancer treatment reports.
[17] E. Nelson,et al. The Measurement of Health Status in Clinical Practice , 1989, Medical care.
[18] D. Tulsky,et al. Reliability and validity of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrument. , 1995, Lung cancer.
[19] D S Tulsky,et al. Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] T M Gill,et al. A critical appraisal of the quality of quality-of-life measurements. , 1994, JAMA.
[21] D. Cella,et al. RTOG's first quality of life study--RTOG 90-20: a phase II trial of external beam radiation with etanidazole for locally advanced prostate cancer. , 1995, International journal of radiation oncology, biology, physics.
[22] K. Taylor,et al. Physicians' perspective on quality of life: An exploratory study of oncologists , 1996, Quality of Life Research.
[23] R. Skeel. Quality of life dimensions that are most important to cancer patients. , 1993, Oncology.
[24] D. Tulsky,et al. Reliability and validity of the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) quality of life instrument , 1999, Quality of Life Research.
[25] N. Boyd,et al. Ratings of the importance of quality of life variables: therapeutic implications for patients with metastatic breast cancer. , 1990, Journal of clinical epidemiology.
[26] Gordon Guyatt,et al. Measuring Health-Related Quality of Life , 1993, Annals of Internal Medicine.
[27] M. Feuerman,et al. Symptom and quality of life survey of medical oncology patients at a Veterans Affairs medical center , 2000, Cancer.
[28] E. Eisenhauer,et al. Palliative effect of chemotherapy: objective tumor response is associated with symptom improvement in patients with metastatic breast cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[29] L. Mackeigan,et al. Overview of health-related quality-of-life measures. , 1992, American journal of hospital pharmacy.
[30] K. Pienta,et al. Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate instrument. , 1997, Urology.
[31] D. Cella,et al. Reliability and validity of the functional assessment of cancer therapy-ovarian. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[32] R. Deyo,et al. Barriers to the Use of Health Status Measures in Clinical Investigation, Patient Care, and Policy Research , 1989, Medical care.
[33] D. V. Von Hoff,et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[34] D. Cella,et al. Quality of life and functional status measures in patients with head and neck cancer. , 1996, Archives of otolaryngology--head & neck surgery.
[35] R. Schulz,et al. Assessing Pharmacotherapy Outcomes: A Model for Clinicians , 1996, Pharmacotherapy.
[36] K. Taylor,et al. Quality-of-life information and clinical practice: the oncologist's perspective. , 1998, Cancer prevention & control : CPC = Prevention & controle en cancerologie : PCC.
[37] G. Browman,et al. Science, language, intuition, and the many meanings of quality of life. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[38] D. Osoba,et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. , 1993, Journal of the National Cancer Institute.